Cite
HARVARD Citation
Kennedy, N. et al. (n.d.). OP03 Anti-SARS-CoV2 antibody responses are attenuated in patients with Inflammatory Bowel Disease treated with infliximab. Journal of Crohn's and colitis. pp. S002-S004. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kennedy, N. et al. (n.d.). OP03 Anti-SARS-CoV2 antibody responses are attenuated in patients with Inflammatory Bowel Disease treated with infliximab. Journal of Crohn's and colitis. pp. S002-S004. [Online].